1. Home
  2. HYFM vs ALZN Comparison

HYFM vs ALZN Comparison

Compare HYFM & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

HOLD

Current Price

$0.89

Market Cap

4.4M

Sector

Industrials

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.22

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYFM
ALZN
Founded
1977
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
3.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
HYFM
ALZN
Price
$0.89
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
13.7K
51.8K
Earning Date
05-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.99
EPS
N/A
N/A
Revenue
$134,252,000.00
N/A
Revenue This Year
$57.44
N/A
Revenue Next Year
$5.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$0.84
52 Week High
$4.78
$3.60

Technical Indicators

Market Signals
Indicator
HYFM
ALZN
Relative Strength Index (RSI) 38.87 56.14
Support Level $0.83 $1.03
Resistance Level $1.07 $1.29
Average True Range (ATR) 0.07 0.07
MACD -0.00 0.01
Stochastic Oscillator 24.32 57.14

Price Performance

Historical Comparison
HYFM
ALZN

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: